Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer

Epidermal growth factor receptor (EGFR) overexpression is common in head and neck squamous cell carcinoma. Targeted therapy specifically directed towards EGFR has been an area of keen interest in head and neck cancer research, as EGFR is potentially an integration point for convergent signaling. Des...

Descripción completa

Detalles Bibliográficos
Autores principales: Byeon, Hyung Kwon, Ku, Minhee, Yang, Jaemoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353966/
https://www.ncbi.nlm.nih.gov/pubmed/30700700
http://dx.doi.org/10.1038/s12276-018-0202-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353966/
https://www.ncbi.nlm.nih.gov/pubmed/30700700
http://dx.doi.org/10.1038/s12276-018-0202-2

Ejemplares similares